Aug 22, 2017 - Top Analyst Reports for Allergan, Ecolab & Exelon
Aug 20, 2017 - A little-known gene-editing pioneer, Editas Medicine, could have what it takes.
Aug 10, 2017 - Shares tumble after the company reports a higher-than-expected loss in the second quarter.
Aug 08, 2017 - It was a quiet month for the commercial-stage biopharma, but that didn't stop its shares from tumbling.
Aug 04, 2017 - Pfizer's (PFE) results were mixed while Teva had a dismal quarter with the company missing estimates as well as cutting its outlook and guidance.
Aug 04, 2017 - Ironwood Pharmaceuticals' (IRWD) second-quarter results were dismal, missing sales and earnings estimates.
Aug 03, 2017 - Allergan Plc (NYSE:AGN)Q2 2017 Earnings CallAugust 03, 2017 8:30 am ETExecutivesDaphne Karydas - Allergan PlcBrenton L. Saunders - Allergan PlcWilliam J. Meury - Allergan PlcC. David Nicholson, Ph.D.
Aug 03, 2017 - Shares plunge after the company reports dreadful second-quarter results and slashes its dividend payment.
Aug 03, 2017 - The big generic and specialty drugmaker struggled in the second quarter due to challenges for its U.S. generics business and Venezuelan uncertainty.
Aug 03, 2017 - Allergan plc (AGN) beat expectations for both earnings and sales in the second quarter. However, shares declined in pre-market trading.